ISSCR News
Natural Component from Licorice Alleviates Inflammatory Bowel Disease in Stem Cell-based Model and in Animals
A new study published today in Stem Cell Reports demonstrates how a human stem cell-derived model of the intestine can be used to identify potential therapies for inflammatory bowel disease (IBD), highlighting glycyrrhizin as a promising candidate for reducing intestinal inflammation and cell death.
The burden of IBD is rising globally, with an estimated 4 million people affected worldwide. The disease is characterized by chronic inflammation of the intestinal wall, leading to symptoms such as persistent diarrhea, abdominal pain, and fatigue. Standard treatments include anti-inflammatory drugs and other immune-targeting therapies, but many patients experience only limited benefit.
The Stem Cell Report Podcast Celebrates Five Years with Special Anniversary Episode
New episode revisits leading voices and major advances featured on the podcast
The International Society for Stem Cell Research (ISSCR) today announced the release of a special anniversary episode of The Stem Cell Report podcast, “Stem Cell-ebration: 5 Years of Breakthrough Science and Insightful Conversations,” marking five years of exploring the science, people, and stories shaping the field. The podcast features work that has published in the ISSCR’s journal, Stem Cell Reports.
The ISSCR Announces 2026 Election Results for Vice President and Board of Directors
The International Society for Stem Cell Research (ISSCR) is delighted to announce the results of its 2026 election for leadership positions, including vice president and members of the Board of Directors.
The election of this leadership cohort reflects ISSCR’s continued evolution as a global platform advancing stem cell science from discovery through clinical impact. With expertise spanning translational science, emerging technologies, ethics, and global policy, the Society is well positioned to guide the responsible and effective advancement of the field at a pivotal moment.
Stem Cell Reports Named Official Journal of 2026 BaCell 3D Conference
The International Society for Stem Cell Research (ISSCR) announces that Stem Cell Reports, its official open-access, peer-reviewed journal, has been named the official journal of the BaCell 3D Organoid Conference, taking place 22-24 June 2026 in Basel, Switzerland.
BaCell 3D brings together leading scientists, innovators, and industry experts at the forefront of organoid technologies, microphysiological systems, and disease modeling. Held annually in one of Europe’s most vibrant life science hubs, the meeting fosters global collaboration and accelerates advances in in vitro multicellular systems that are transforming biomedical research.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .